Use of proteomic analysis of LKB1/AMPK/mTOR pathways to identify IGF-1R pathway upregulation with LKB1 loss or mTOR inhibition in NSCLC: Implications for targeted combinations.
Emrullah Yilmaz
No relevant relationships to disclose
Lauren Averett Byers
No relevant relationships to disclose
Lixia Diao
No relevant relationships to disclose
Uma Giri
No relevant relationships to disclose
Jayanthi Gudikote
No relevant relationships to disclose
You Hong Fan
No relevant relationships to disclose
Jing Wang
No relevant relationships to disclose
Kevin R. Coombes
No relevant relationships to disclose
Luc Girard
No relevant relationships to disclose
John D. Minna
No relevant relationships to disclose
John Heymach
No relevant relationships to disclose